News
Healthcare Asia Magazine on MSN6d
7MM regulatory T-cell market to grow over 57% CAGR by 2034Currently, no Treg-based therapies are approved. The regulatory T-cells (Tregs) sector across the seven major markets (7MM) ...
11d
Live Science on MSNEstrogen may spur the body to make opioids after injuryThe female sex hormone estrogen, along with progesterone, appears to underlie a fundamental difference in how males and ...
In a breakthrough finding, researchers have discovered that immune cells near the spinal cord are triggered by estrogen and ...
In cultures of both human cells and living mice, engineered regulatory T cells were able to simmer down gluten-reactive effector T cells that cause the characteristic autoimmune response seen in ...
The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at Tr1X, with patients enrolling at leading stem cell transplant centers across ...
Scientists have discovered that female hormones like estrogen and progesterone can trigger immune cells near the spinal cord to release natural opioids, easing pain before it reaches the brain.
Nektar Therapeutics’s NKTR share price has surged by 18.21%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results